← FDA DRUG APPROVALS

FDA ANDA · ANDA080017

FURALAN

Sponsor: CHARTWELL MOLECULAR

APPLICATION
ANDA080017
TYPE
ANDA
ORIGINAL APPROVAL
1970-09-30
LATEST ACTION
2014-06-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

FURALANDiscontinued
NITROFURANTOIN 100MG · TABLET · ORAL
FURALANDiscontinued
NITROFURANTOIN 50MG · TABLET · ORAL

Approval history

2014-06-25Labeling · Supplement 1 · standardAP
1970-09-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →